SoxB transcription factors specify neuroectodermal lineage choice in ES cells.
about
Notch promotes neural lineage entry by pluripotent embryonic stem cells.Dynamic transcriptomes during neural differentiation of human embryonic stem cells revealed by short, long, and paired-end sequencingThe transcriptional foundation of pluripotencyThe Importance of Ubiquitination and Deubiquitination in Cellular ReprogrammingNeuromesodermal progenitors and the making of the spinal cordStem cell-based models and therapies for neurodegenerative diseasesElevated FOXG1 and SOX2 in glioblastoma enforces neural stem cell identity through transcriptional control of cell cycle and epigenetic regulators.Ectopic expression of neurogenin 2 alone is sufficient to induce differentiation of embryonic stem cells into mature neurons.Regional differentiation of retinoic acid-induced human pluripotent embryonic carcinoma stem cell neurons.A blueprint for engineering cell fate: current technologies to reprogram cell identity.Pharmacological Reprogramming of Fibroblasts into Neural Stem Cells by Signaling-Directed Transcriptional Activation.Sox3 functions in a cell-autonomous manner to regulate spermatogonial differentiation in mice.Sox2 Level Is a Determinant of Cellular Reprogramming Potential.Flexibility of neural stem cellsSox2 modulates reprogramming of gene expression in two-cell mouse embryos.Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genesPhenazopyridine induces and synchronizes neuronal differentiation of embryonic stem cells.Sox1 marks an activated neural stem/progenitor cell in the hippocampus.Neural induction and neural stem cell development.Neuronal specificity of HSV/sleeping beauty amplicon transduction in utero is driven primarily by tropism and cell type compositionStem cells in development of therapeutics for Parkinson's disease: a perspectivePotential sources of stem cells as a regenerative therapy for Parkinson's disease.Neural commitment of embryonic stem cells: molecules, pathways and potential for cell therapy.Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cellsStem cell factor Sox2 and its close relative Sox3 have differentiation functions in oligodendrocytesA role for mitotic bookmarking of SOX2 in pluripotency and differentiationLoss of ZNF32 augments the regeneration of nervous lateral line system through negative regulation of SOX2 transcriptionPluripotent genes in avian stem cells.Concise review: the involvement of SOX2 in direct reprogramming of induced neural stem/precursor cellsCellular reprogramming of human peripheral blood cellsFrom CNS stem cells to neurons and glia: Sox for everyone.Can the 'neuron theory' be complemented by a universal mechanism for generic neuronal differentiation.Eya1 and Six1 promote neurogenesis in the cranial placodes in a SoxB1-dependent fashion.TRPV3 Channel Negatively Regulates Cell Cycle Progression and Safeguards the Pluripotency of Embryonic Stem Cells.Identifying gene expression modules that define human cell fatesA Sox1 to Pax6 switch drives neuroectoderm to radial glia progression during differentiation of mouse embryonic stem cells.Xenopus Sox3 activates sox2 and geminin and indirectly represses Xvent2 expression to induce neural progenitor formation at the expense of non-neural ectodermal derivatives.Sox2, a key factor in the regulation of pluripotency and neural differentiationThe function of e-cadherin in stem cell pluripotency and self-renewalSox2: A multitasking networker.
P2860
Q21146059-B105C58D-286F-4098-9540-C761CFA346A1Q24620865-61A59FF6-3EE8-4DC1-B9AC-10FE9E564254Q24649039-394AC272-4CDA-470D-B87A-0039C44A68B6Q26765873-36E1234F-832E-4FB3-84C8-59A77ED173EDQ26795449-3A7CEBA1-77AB-49DA-8B69-11554A6E5CA8Q30451005-C8776641-0146-449D-BD93-AAC1325E44EBQ30851277-33CF0DA7-55D3-46E0-BA25-68D5A2EDEFFEQ31066354-DA114FFA-328C-4892-8E9C-2BB91A6B4B50Q33809316-F8B1A1FA-640B-4A09-A07B-335C5EC5BC62Q34320191-F7E5C8BA-EC2F-4879-8115-E88266E1BE0DQ34524445-673AF855-3A95-4B5C-BE54-A74880F1B03EQ34697057-18C43D9C-1C13-4038-8036-F0B068F75840Q34795039-5630A5F2-9E41-4C61-B081-E2BFAE20A494Q34820457-3578F511-374A-43EB-98FB-9346E6844A67Q35124099-2FC3A7F0-0719-43B5-93CE-6F703FA1C870Q35804584-579CAAF1-00AC-40C8-B5EC-2B4961AE000DQ35893332-A4CCF344-7360-4760-9AD7-564CD2F3264EQ36321303-4FAA483B-D21A-4102-9DD0-0E5CC9D46B81Q36804464-A9D22ED9-F5F0-4151-9FC8-CE92E6BB3197Q36983992-5D05343E-1B4D-4D59-94CB-BD102F948FFCQ37002530-87E6EACC-76F1-460C-BD07-D5CCB7993284Q37194111-83C4FD1F-B1D4-419C-9140-6A7CEB5FA7B2Q37195884-7582AF96-1F7C-44CD-9669-8A806F85C68BQ37385808-1D889876-FFB5-44A8-9723-879070F0B56EQ37398468-AB55AC1D-27EF-4FAE-B2B0-46B70C96B429Q37507945-07369042-F884-4A8D-B55C-A44203102E6DQ37688547-25548010-6B03-4DEE-B959-75742E4BCCA7Q38070797-9EF57F5B-01A6-45A0-814E-E860CD62C125Q38118544-F987A062-765D-4E93-A3D2-D9D7F7D3945AQ38141509-A780AB28-AFCA-4E31-8653-01F1A1A43858Q38217396-410053EB-4068-4495-B844-0D69BB72D260Q38272073-7F085BB6-CFA2-440B-9E70-1365C8D9DF23Q38289851-966473DA-3187-40EF-8BA5-7A8B8300B60EQ38858315-415A6EA4-E7D8-4778-8277-59F981C8B3FBQ39827214-818A4072-D908-4182-972B-5214DFEBE450Q39933004-5BBFD49D-4E54-4152-845F-66539350EE25Q41896090-087BD703-A20F-4160-90A4-7C367D303053Q41903725-D640FFA7-F3FE-45A8-A897-FFB124F4C7FAQ41956122-F3597676-9681-4098-8D6C-C61076534B19Q42152155-DED7D98B-DF43-4BAB-AABE-7D9A6A3B5A18
P2860
SoxB transcription factors specify neuroectodermal lineage choice in ES cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
SoxB transcription factors specify neuroectodermal lineage choice in ES cells.
@en
type
label
SoxB transcription factors specify neuroectodermal lineage choice in ES cells.
@en
prefLabel
SoxB transcription factors specify neuroectodermal lineage choice in ES cells.
@en
P2093
P1476
SoxB transcription factors specify neuroectodermal lineage choice in ES cells.
@en
P2093
Jennifer Nichols
Suling Zhao
P304
P356
10.1016/J.MCN.2004.08.002
P50
P577
2004-11-01T00:00:00Z